CN109010317A - 一种富马酸替诺福韦二吡呋酯颗粒及其制备方法 - Google Patents
一种富马酸替诺福韦二吡呋酯颗粒及其制备方法 Download PDFInfo
- Publication number
- CN109010317A CN109010317A CN201810803322.8A CN201810803322A CN109010317A CN 109010317 A CN109010317 A CN 109010317A CN 201810803322 A CN201810803322 A CN 201810803322A CN 109010317 A CN109010317 A CN 109010317A
- Authority
- CN
- China
- Prior art keywords
- tenofovir disoproxil
- disoproxil fumarate
- preparation
- mesh
- particle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
组别 | 苦味评分 | 苦味等级 |
实施例1 | 1.0 | Ⅰ |
实施例2 | 0.75 | Ⅰ |
实施例3 | 0.5 | Ⅰ |
对比例1 | 5.5 | Ⅴ |
对比例2 | 3.25 | Ⅲ |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810803322.8A CN109010317A (zh) | 2018-07-20 | 2018-07-20 | 一种富马酸替诺福韦二吡呋酯颗粒及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810803322.8A CN109010317A (zh) | 2018-07-20 | 2018-07-20 | 一种富马酸替诺福韦二吡呋酯颗粒及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109010317A true CN109010317A (zh) | 2018-12-18 |
Family
ID=64644628
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810803322.8A Pending CN109010317A (zh) | 2018-07-20 | 2018-07-20 | 一种富马酸替诺福韦二吡呋酯颗粒及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109010317A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113599366A (zh) * | 2021-08-12 | 2021-11-05 | 南京海纳医药科技股份有限公司 | 一种富马酸替诺福韦二吡呋酯颗粒及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009106954A1 (en) * | 2008-02-27 | 2009-09-03 | Aurobindo Pharma Limited | Stable dosage forms of lamivudine and tenofovir |
CN103330683A (zh) * | 2013-06-26 | 2013-10-02 | 神威药业集团有限公司 | 一种富马酸替诺福韦酯细粒剂 |
CN103690552A (zh) * | 2013-11-29 | 2014-04-02 | 蒋爱芳 | 一种药物组合物及其在制备治疗乙型肝炎药物制剂中的应用 |
CN103705478A (zh) * | 2013-12-23 | 2014-04-09 | 浙江华海药业股份有限公司 | 含有富马酸替诺福韦二吡呋酯的口服片剂 |
CN104277073A (zh) * | 2014-09-19 | 2015-01-14 | 四川海思科制药有限公司 | 一种富马酸替诺福韦二吡呋酯化合物 |
CN104644598A (zh) * | 2014-12-05 | 2015-05-27 | 乐普药业股份有限公司 | 富马酸替诺福韦二吡呋酯片 |
-
2018
- 2018-07-20 CN CN201810803322.8A patent/CN109010317A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009106954A1 (en) * | 2008-02-27 | 2009-09-03 | Aurobindo Pharma Limited | Stable dosage forms of lamivudine and tenofovir |
CN103330683A (zh) * | 2013-06-26 | 2013-10-02 | 神威药业集团有限公司 | 一种富马酸替诺福韦酯细粒剂 |
CN103690552A (zh) * | 2013-11-29 | 2014-04-02 | 蒋爱芳 | 一种药物组合物及其在制备治疗乙型肝炎药物制剂中的应用 |
CN103705478A (zh) * | 2013-12-23 | 2014-04-09 | 浙江华海药业股份有限公司 | 含有富马酸替诺福韦二吡呋酯的口服片剂 |
CN104277073A (zh) * | 2014-09-19 | 2015-01-14 | 四川海思科制药有限公司 | 一种富马酸替诺福韦二吡呋酯化合物 |
CN104644598A (zh) * | 2014-12-05 | 2015-05-27 | 乐普药业股份有限公司 | 富马酸替诺福韦二吡呋酯片 |
Non-Patent Citations (4)
Title |
---|
国家药典委员会: "《中华人民共和国药典2010版第二增补本》", 30 September 2013, 中国医药科技出版社 * |
张伟华: "《药物制剂技术及其发展探究》", 31 August 2017, 科学技术文献出版社 * |
杨世民等主编: "《2018国家执业药师考试辅导用书 药学专业知识(一)》", 31 January 2018, 中国医药科技出版社 * |
葛洪等主编: "《新编临床药物学》", 31 March 2018, 吉林科学技术出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113599366A (zh) * | 2021-08-12 | 2021-11-05 | 南京海纳医药科技股份有限公司 | 一种富马酸替诺福韦二吡呋酯颗粒及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Suryadevara et al. | Studies on jackfruit seed starch as a novel natural superdisintegrant for the design and evaluation of irbesartan fast dissolving tablets | |
CN1899361B (zh) | 贞芪药物组合及其制备 | |
CN102198110B (zh) | 富马酸替诺福韦二吡呋酯分散片及其制备方法 | |
WO2021043227A1 (zh) | 用于口腔掩味的含氢溴酸沃替西汀的包衣颗粒、固体分散体和制剂 | |
JP2016539955A (ja) | 薬物組成物、及びその製造方法、並びに使用 | |
JP2016540833A (ja) | 広金銭草総フラボノイドカプセル剤およびその製造方法、並びにその応用 | |
CN109010317A (zh) | 一种富马酸替诺福韦二吡呋酯颗粒及其制备方法 | |
CN109988104A (zh) | 山奈酚与异烟酰胺共晶物及制备方法和其药物组合物与用途 | |
CN101461898B (zh) | 治疗更年期综合征的中药固体制剂及其制备方法 | |
CN103316056A (zh) | 一种板蓝根包衣分散片及其制备方法 | |
CN104127510B (zh) | 小儿热速清颗粒矫味组合物及其颗粒剂和制法 | |
CN100420471C (zh) | 滋肾养肺的中药口服制剂及其制备方法 | |
CN109232297A (zh) | 芬乐胺晶b型、制备方法和其组合物与用途 | |
CN107375225B (zh) | 一种琥珀酸呋罗曲坦缓释制剂及其制备方法 | |
CN101249119B (zh) | 复方氨酚葡锌分散片及其制备方法 | |
CN101991859A (zh) | 一种石杉碱甲的β-环糊精包合物及其制备方法和制剂 | |
CN100441171C (zh) | 一种治疗血证的分散片及其制备方法和用途 | |
CN113599366B (zh) | 一种富马酸替诺福韦二吡呋酯颗粒及其制备方法 | |
CN1768794B (zh) | 治疗呼吸道系统疾病的中药制剂及其制备方法 | |
CN101244068B (zh) | 雪胆素缓释制剂 | |
CN110496141B (zh) | 一种含冬虫夏草的药物组合物 | |
JPS61194031A (ja) | 制癌作用増強剤 | |
CN1823961B (zh) | 治疗感冒引起的咳喘、急性支气管炎的中药复方制剂及其制备方法 | |
CN100515412C (zh) | 一种中药片剂及其制备方法 | |
CN1813886B (zh) | 用于活血化瘀、通脉止痛的银盏心脉中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190530 Address after: 210009 15 Floor, No. 5 New Model Road, Gulou District, Nanjing City, Jiangsu Province Applicant after: Nanjing Haina pharmaceutical Polytron Technologies Inc Applicant after: Nanjing Haina Pharmaceutical Co., Ltd. Applicant after: Nanjing Yinuo Pharmaceutical Technology Co., Ltd. Address before: 210009 15 Floor, No. 5 New Model Road, Gulou District, Nanjing City, Jiangsu Province Applicant before: Nanjing Haina pharmaceutical Polytron Technologies Inc Applicant before: Nanjing Haina Pharmaceutical Co., Ltd. |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181218 |